Why does smallpox vaccine shield some, not others? It's in the genes, study finds

April 18, 2013

How well people are protected by the smallpox vaccine depends on more than the quality of the vaccination: individual genes can alter their response, Mayo Clinic research shows. The findings, gathered using sophisticated genomic screening, appear in today's online issue of the journal Genes and Immunity.

"We were looking into the intercellular reactions that occur when vaccinated and unvaccinated persons are exposed to and infected with . We were able to use blood samples taken directly from vaccinated patients," says senior author Gregory Poland, M.D., director of the Mayo Clinic Group. "We could see what would happen based on exposing a mixed-cell peripheral blood to the vaccinia virus."

While worldwide vaccination is believed to have eradicated smallpox, the highly contagious and sometimes fatal illness remains a bioterrorism concern.

Researchers studied 44 participants from Mayo Clinic and the Naval Health Research Center who had received the in the previous 48 months. Two samples were prepared from each of the 44, one uninfected and one that was infected with vaccinia, a smallpox-like virus. RNA (ribonucleic acid, molecules that represent the DNA makeup) from the samples was then tested in the high-speed sequencing facilities at Mayo Clinic's Center for Individualized Medicine. were found between people with robust protective antibodies and those with lower immunity from smallpox.

Dr. Poland says this individualized medicine approach and its findings offer researchers new targets for developing tests to determine if a person should receive a specific vaccine, but also an opportunity to develop new vaccines to benefit non-responders.

Explore further: Mayo Clinic physician: Mistaken fear of measles shot has 'devastating' effect

Related Stories

Recommended for you

New class of RNA tumor suppressors identified

November 23, 2015

A pair of RNA molecules originally thought to be no more than cellular housekeepers are deleted in over a quarter of common human cancers, according to researchers at the Stanford University School of Medicine. Breast cancer ...

Batten disease may benefit from gene therapy

November 11, 2015

In a study of dogs, scientists showed that a new way to deliver replacement genes may be effective at slowing the development of childhood Batten disease, a rare and fatal neurological disorder. The key may be to inject viruses ...

Molecular clocks control mutation rate in human cells

November 9, 2015

Every cell in the human body contains a copy of the human genome. Through the course of a lifetime all cells are thought to acquire mutations in their genomes. Some of the mutational processes generating these mutations do ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.